Genetics and genomics in neuropsychopharmacology: the impact on drug discovery and development

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.11, Iss.6, 2001-12, pp. : 491-499

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

From genetics and genomics to drug discovery: yeast rises to the challenge

By Melese T. Hieter P.

Trends in Pharmacological Sciences, Vol. 23, Iss. 12, 2002-12 ,pp. : 544-547

Elsevier

Access to resources Recommend Favorite

Advances in Drug Discovery: Impact of Genomics and Role of Analytical Instrumentation

Current Drug Discovery Technologies, Vol. 13, Iss. 4, 2016-12 ,pp. : 211-224

Bentham Science Publishers

Access to resources Recommend Favorite

Genomics and drug discovery

By Van Oosterhout A.J.M.

Trends in Pharmacological Sciences, Vol. 19, Iss. 5, 1998-05 ,pp. : 157-160

Elsevier

Access to resources Recommend Favorite

Antimycotic Drug Discovery in the Age of Genomics

By Cleary John D.

American Journal of PharmacoGenomics, Vol. 5, Iss. 6, 2005-01 ,pp. : 365-386

Adis International

Access to resources Recommend Favorite

In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery

By Darvesh Altaf S Carroll Richard T Geldenhuys Werner J Gudelsky Gary A Klein Jochen Meshul Charles K Van der Schyf Cornelis J

Expert Opinion on Drug Discovery, Vol. 6, Iss. 2, 2011-02 ,pp. : 109-127

Informa Healthcare

Access to resources Recommend Favorite